Abstract
The effects of natural cyclodepsipeptides (CDPs) on isolated rat cardiac tissue preparations were examined in vitro. Destruxin A, destruxin B (DB), roseotoxin B (RB), and roseocardin (RC), a novel CDP, each caused a concentration-dependent increase in the contraction force of the right atrium and the papillary and trabecular muscles of the right ventricle at 0.6 to 600 μM. RB, destruxin A, and DB did not affect the half-decay time of relaxation of the papillary muscles, but RC slightly prolonged it, although to a much lesser extent than BA 41899, a calcium sensitizer. This inotropic effect is accompanied by a prolongation of the automatic atrial contraction intervals. The RB-induced increase in the contraction force of papillary muscle was not affected by phentolamine, propranolol, pyrilamine, or cimetidine. RB- and RC-induced increases in the contraction force of papillary muscles were not affected by 3-isobutyl-1-methylxanthine or carbachol. Neither peptide changed the cyclic AMP levels in trabecular muscles. Neither RB nor RC affected the activity of Na+,K+-ATPase from rat kidney. Neither RB, RC, nor DB affected the resting membrane potential or the apparent input resistance of papillary muscles. These results suggest that these CDPs produce both non-cyclic AMP-dependent positive inotropic and negative chronotropic effects.
Footnotes
-
Send reprint requests to: Dr. Akinobu Tsunoo, Meiji Institute of Health Science, Meiji Milk Products Co., Ltd., 540 Naruda, Odawara, Kanagawa, 250-0862, Japan.
-
↵1 A preliminary report of this study was presented in the 70th Scientific Sessions of the American Heart Association [Tsunoo A and Kamijo M (1997) Cyclodepsipeptides: A novel positive inotropic agent with a noncAMP dependent mechanism. Circulation96 (Suppl 1):1-611].
- Abbreviations:
- cAMP
- cyclic AMP
- CDP
- cyclodepsipeptide
- DA
- destruxin A
- DB
- destruxin B
- IBMX
- 3-isobutyl-1-methylxanthine
- RB
- roseotoxin B
- RC
- roseocardin
- Received December 2, 1998.
- Accepted May 3, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|